CHARACTERIZATION OF THE POSITIVE AND NEGATIVE INOTROPIC EFFECTS OF ACETYLCHOLINE IN THE HUMAN MYOCARDIUM

Citation
Xy. Du et al., CHARACTERIZATION OF THE POSITIVE AND NEGATIVE INOTROPIC EFFECTS OF ACETYLCHOLINE IN THE HUMAN MYOCARDIUM, European journal of pharmacology, 284(1-2), 1995, pp. 119-127
Citations number
47
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
284
Issue
1-2
Year of publication
1995
Pages
119 - 127
Database
ISI
SICI code
0014-2999(1995)284:1-2<119:COTPAN>2.0.ZU;2-B
Abstract
In the human isolated myocardium, acetylcholine (10(-9) to 10(-3) M) e licited a biphasic inotropic effect (a decrease in the lower and an in crease in the higher concentration range) in atrial and a positive ino tropic effect in ventricular trabeculae. However, under conditions of raised contractility achieved by exposure to noradrenaline (10(-5) M), only negative inotropic effects were observed in both atria and ventr icles. Atropine (10(-6) M), but not propranolol(10(-6) M), antagonized both positive and negative inotropic effects of acetylcholine, thus s howing that the responses were mediated by muscarinic acetylcholine re ceptors. The use of subtype selective muscarinic receptor antagonists (10(-7) to 10(-5) M), pirenzepine (M(1) > M(3) > M(2)), AF-DX 116 dihy dro-6H-pyridol[2,3-b][1,4]benzodiazepine-6-one base; M(2) > M(1) > M(3 )) and HHSiD (p-fluorohexahydro-siladifenidol hydrochloride; M(3) grea ter than or equal to M(1) >> M(2)) revealed that the negative inotropi c effect of acetylcholine in atrial as well as the positive inotropic effect in ventricular trabeculae were best antagonized by AF-DX 116 an d not by pirenzepine, suggesting the involvement of the muscarinic M(2 ) receptor subtype, possibly linked to different second messenger syst ems. On the other hand, the positive inotropic effect of acetylcholine (10(-6) to 10(-3) M) in the atrial tissue, observed only in preparati on with depressed contractility, was not effectively antagonized by ei ther AF-DX 116 or HHSiD, but was significantly reduced by pirenzepine. Furthermore, the selective muscarinic M(1), receptor agonist McN-A-34 3 (4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethyl ammonium chloride ; 10(-9) to 10(-3) M), which failed to significantly change the baseli ne contractility in either atrial or ventricular trabeculae, produced a positive inotropic effect in atrial preparations when contractility had been depressed by prior treatment with acetylcholine (10(-9) to 10 (-7) M). This effect of McN-A-343 was effectively antagonized by piren zepine (10(-5) M). These data show that, besides the muscarinic M(2) r eceptor mediating both negative (atria) and positive (ventricle) inotr opic effects, muscarinic M(1) receptors, capable of reversing depresse d atrial contractility, are present in the human heart.